Manipal Hospital, Dhakuria has become the first center in Eastern India to successfully implant Abbott’s Aveir Leadless pacemaker, marking a significant advancement in cardiac care. The innovative device, recently introduced to the Indian market, was first implanted in a 65-year-old patient. The wireless pacemaker, weighing just 2.4 grams, employs nanotechnology and boasts a lifespan of 20-25 years – nearly triple that of conventional pacemakers. Its Bluetooth-enabled technology allows for remote monitoring, while its non-magnetic design ensures compatibility with MRI machines and airport scanners.
Dr. P.K. Hazra, Interventional Cardiologist at Manipal Hospital, highlighted the device’s unique ability to be upgraded from single to dual-chamber configuration, effectively regulating both the right atrium and ventricle. The minimally invasive procedure eliminates the need for external wires and surgical pockets, reducing infection risks and complications.
India joins the United States and Europe as the third country to implement this USFDA and European Medical Authority-approved device. The innovation is expected to benefit patients from neighboring countries like Bhutan, where cardiovascular diseases remain a significant health challenge.